Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: v


Summaries of Product Characteristics 1 - 30 of 198
  1  2  3  4  5  6  7  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

V-Pen 50 mg-ml rakeet oraaliliuosta varten SPC 2022-06-17

PL

Resepti

V-Pen 500, V-Pen mega, V-Pen 1500 tabletti, kalvopäällysteinen SPC 2020-11-19.doc

European Medicines Agency's website:
Vaborem (ent. Vabomere) - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Vabysmo - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Vagidonna 10 mikrog emätinpuikko, tabletti SPC 2022-02-21

PL

Resepti

Vagifem 10 mikrog emätinpuikko, tabletti SPC 2022-08-04

PL

Resepti

Vagiprev ,120 mg-0,015 mg per 24 tuntia, depotlääkevalmiste, emättimeen SPC 2022-01-17

PL

Resepti

Vagirux 0,01 mg emätinpuikko,tabletti SPC 2022-04-15

PL

Resepti/itsehoito

Valaciclovir ratiopharm 500 mg tabletti, kalvopäällysteinen SPC 2021-07-29

PL

Resepti

Valarox 10 mg_80 mg, 20 mg_80 mg, 10 mg_160 mg, 20 mg_160 mg tabletti, kalvopäällysteinen SPC 2017-01-27

PL

Resepti/itsehoito

Valavir 500 mg tabletti, kalvopäällysteinen SPC 2021-03-12

PL

Resepti

Valcyte 50 mg-ml jauhe oraaliliuosta varten SPC 2021-12-17

European Medicines Agency's website:
Valdoxan - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Valeriamed yö-natt tabletti, päällystetty SPC 2016-09-19

PL

Resepti

Valganciclovir Accord 450 mg tabletti, kalvopäällysteinen SPC 2022-01-19

PL

Resepti

Valganciclovir Orion 450 mg tabletti, kalvopäällysteinen SPC 2022-01-28

PL

Resepti

Valganciclovir Sandoz 450 mg tabletti, kalvopäällysteinen SPC 2020-11-26

PL

Resepti/itsehoito

Valorin 500 mg tabletti, kalvopäällysteinen SPC 2021-03-02

PL

Resepti

Valproat Life Medical 100 mg-ml injektio-infuusioneste, liuos SPC 2022-10-28 Uusi

PL

Resepti

Valproat Sandoz 300 mg, 500 mg depottabletti SPC 2022-04-21

PL

Resepti

Valsarstad 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2020-10-21

PL

Resepti

Valsartan Actavis 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2021-04-12

PL

Resepti

Valsartan Krka 320 mg tabletti, kalvopäällysteinen SPC 2022-09-30

PL

Resepti

Valsartan Krka 40 mg, 80 mg, 160 mg tabletti, kalvopäällysteinen SPC 2022-01-31

PL

Resepti

Valsartan Sandoz 80 mg, 160 mg tabletti, kalvopäällysteinen SPC 2021-05-20

PL

Resepti

Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen SPC 2022-07-20

PL

Resepti

Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen SPC 2022-07-20

PL

Resepti

Valsartan-Hydrochlorothiazide Sandoz 80 mg-12.5 mg, 160 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2022-03-31

PL

Resepti

Valsartan-Hydroklortiazid Actavis 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen SPC 2022-02-10

PL

Resepti

Valsartan/Hydroklortiazid Actavis 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg tabletti, kalvopäällysteinen SPC 2021-11-30

  1  2  3  4  5  6  7  |  Next 30   >